Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 5/20 | 0.46 |
| ▸ | DPP4 | P27487 | 5/20 | 0.46 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.45 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 5/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.33 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24011906 | 0.94 | DPP4 (0.43) | ANPEPDPP4NR1H2NR1H3ADRB2 | |
| SCHEMBL20412268 | 0.93 | ANPEP (0.50) | ANPEPDPP4NR1H2NR1H3ADRB2 | |
| SCHEMBL24012109 | 0.90 | ANPEP (0.45) | ANPEPDPP4NR1H2NR1H3LMNA | |
| SCHEMBL24012251 | 0.89 | DPP4 (0.49) | ANPEPDPP4NR1H2NR1H3ADRB2 | |
| SCHEMBL11954355 | 0.89 | ANPEP (0.47) | ANPEPDPP4NR1H2NR1H3ADRB2 | |
| SCHEMBL25868389 | 0.88 | ANPEP (0.43) | ANPEPDPP4NR1H2NR1H3ADRB2 | |
| SCHEMBL24011807 | 0.88 | ANPEP (0.43) | ANPEPDPP4NR1H2NR1H3ADRB2 | |
| SCHEMBL12482639 | 0.87 | ANPEP (0.48) | ANPEPDPP4NR1H2NR1H3ADRB2 | |
| SCHEMBL24011806 | 0.86 | ANPEP (0.44) | ANPEPDPP4NR1H2NR1H3ADRB2 | |
| SCHEMBL24011828 | 0.86 | DPP4 (0.46) | ANPEPDPP4NR1H2NR1H3ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | Konica Minolta, Inc. (JP) | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | IGF1R, IK, BMI1 | ANPEP 4805/4885DPP4 4366/4885NR1H2 1914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.